CSIR’s indigenously developed Paracetamol announced by Dr Jitendra Singh EP News Bureau Jan 6, 2025 Karnataka-based Satya Deeptha Pharmaceuticals will utilise this breakthrough to produce affordable paracetamol domestically
We, at OmniActive, invest over 10 per cent of the total outlay into R&D Viveka Roychowdhury Dec 2, 2024 Sanjaya Mariwala, Executive Chairman and MD, OmniActive Health Technologies shares insights into the company’s significant…
DSIR renews recognition for Venus Remedies’ R&D unit EP News Bureau May 16, 2023 The company invested 3.53 per cent of its total sales in R&D, from which it has generated 5.25 per cent of its total revenue,…
